The Queen’s Biotech Investment Council (QBIC) is a student-run council at Queen’s University in Kingston that bridges the gap between commerce, health sciences, and biotechnology.
Equity research
Publication of fundamental equity research, commercial valuation models, and clinical pipeline analyses
Portfolio management
Workshops and active simulated portfolio management focused on clinical-stage biopharma
Competitions
Leading an inter-provincial biotech stock pitch competition
Our analysts cover a sector of biotech, read the primary trial data and build valuation models. Each semester ends with a collaborative written paper reviewed by peers.
We especially encourage health sciences, life sciences, and biology students to apply to become a research analyst.
Our traders separate into sub-teams and pitch ideas by the end of the first month, competing internally to build a viable portfolio composed of biotech and pharmaceutical companies.
This department strongly encourages commerce students to apply, however, any health science, life science, or biology major is encouraged to send in an application - especially those with trading experience or knowledge.
Coming up
The first biotech stock pitch competition held by QBIC. First-year students from universities across Canada pitch a highly volatile biotech or pharma stock from a pre-selected list and defend it before a panel.
First-year hiring for the 2027 - 2028 year will commence in September 2027. Both divisions will be hiring. Prior finance or life sciences experience is not required; a demonstrated curiosity for healthcare capital markets and strong analytical drive are strongly preferred.
